ARTICLE | Clinical News

Vitor: Development halted

February 1, 2010 8:00 AM UTC

Ark plans to place development of Vitor on hold as part of an ongoing restructuring to conserve cash. The company said a change in trial design is required for a Phase III trial of Vitor to treat canc...